Haoxi Health Tech Exchanges Series A Warrants

Ticker: HAO · Form: 6-K · Filed: Nov 27, 2024 · CIK: 1954594

Haoxi Health Technology LTD 6-K Filing Summary
FieldDetail
CompanyHaoxi Health Technology LTD (HAO)
Form Type6-K
Filed DateNov 27, 2024
Risk Levelmedium
Pages1
Reading Time2 min
Key Dollar Amounts$0.0001, $0.6
Sentimentneutral

Sentiment: neutral

Topics: warrants, exchange-agreement, dilution

TL;DR

Haoxi Health Tech is swapping out old warrants for new ones, watch for share dilution.

AI Summary

On November 27, 2024, Haoxi Health Technology Limited entered into a warrant exchange agreement with holders of 3,998,000 Series A warrants. This agreement allows for the exchange of these warrants, each convertible into five Class A ordinary shares.

Why It Matters

This warrant exchange could impact the company's outstanding share count and potentially dilute existing shareholders if the warrants are exercised.

Risk Assessment

Risk Level: medium — The exchange of a significant number of warrants could lead to increased share dilution and affect the stock price.

Key Numbers

Key Players & Entities

FAQ

What are the terms of the warrant exchange agreement?

The filing states that Haoxi Health Technology Limited entered into a warrant exchange agreement with certain holders of 3,998,000 Series A warrants on November 27, 2024. Specific terms of the exchange are not detailed in this excerpt.

What is the par value of the Class A ordinary shares?

The par value of the Class A ordinary shares is $0.0001 per share.

Who are the parties involved in the exchange agreement?

The parties are Haoxi Health Technology Limited (the "Company") and certain holders (the "Holders") of Series A warrants.

How many Class A ordinary shares can each Series A warrant be converted into?

Each Series A warrant is to purchase five Class A ordinary shares.

What is the filing date of this report?

This Form 6-K was filed as of November 27, 2024.

Filing Stats: 385 words · 2 min read · ~1 pages · Grade level 13.8 · Accepted 2024-11-27 09:15:44

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Haoxi Health Technology Limited Date: November 27, 2024 By: /s/ Zhen Fan Name: Zhen Fan Title: Chief Executive Officer 2

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing